Zymeworks Inc (ZYME)
8.81
-0.42
(-4.55%)
USD |
NASDAQ |
May 10, 16:00
8.81
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Profit Margin (Quarterly): -315.6% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -315.6% |
December 31, 2023 | -85.56% |
September 30, 2023 | -173.8% |
June 30, 2023 | -730.5% |
March 31, 2023 | -68.45% |
December 31, 2022 | 76.88% |
September 30, 2022 | -1.82K% |
June 30, 2022 | -1.19K% |
March 31, 2022 | -3.79K% |
December 31, 2021 | -197.0% |
September 30, 2021 | -1.38K% |
June 30, 2021 | -3.81K% |
March 31, 2021 | -6.92K% |
December 31, 2020 | -241.7% |
September 30, 2020 | -2.75K% |
June 30, 2020 | -315.2% |
March 31, 2020 | -376.5% |
Date | Value |
---|---|
December 31, 2019 | -3.85K% |
September 30, 2019 | -387.7% |
June 30, 2019 | -368.9% |
March 31, 2019 | -114.4% |
December 31, 2018 | 32.06% |
September 30, 2018 | -912.9% |
June 30, 2018 | -26.70% |
March 31, 2018 | -53.01K% |
December 31, 2017 | 65.37% |
September 30, 2017 | -13.65K% |
June 30, 2017 | -817.3% |
March 31, 2017 | -6.92K% |
December 31, 2016 | -505.2% |
September 30, 2016 | -570.8% |
June 30, 2016 | -117.0% |
March 31, 2016 | -1.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.92K%
Minimum
Mar 2021
76.88%
Maximum
Dec 2022
-1.43K%
Average
-382.1%
Median
Profit Margin (Quarterly) Benchmarks
Emergent BioSolutions Inc | 3.08% |
MariMed Inc | -26.14% |
Viemed Healthcare Inc | 3.17% |
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -28.00% |
Return on Assets | -21.77% |
Return on Invested Capital | -28.00% |
Operating Margin (Quarterly) | -376.9% |
Return on Net Operating Assets | -101.3% |